Device
Silverlon
Silverlon is a medical device with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Total Trials
7
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
83.3%
Based on 5 completed trials
Completion Rate
83%(5/6)
Active Trials
1(14%)
Results Posted
100%(5 trials)
Terminated
1(14%)
Phase Distribution
Ph phase_4
1
14%
Ph phase_1
1
14%
Ph not_applicable
5
71%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
5(71.4%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
83.3%
5 of 6 finished
Non-Completion Rate
16.7%
1 ended early
Currently Active
1
trials recruiting
Total Trials
7
all time
Status Distribution
Active(1)
Completed(5)
Terminated(1)
Detailed Status
Completed5
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
7
Active
1
Success Rate
83.3%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (14.3%)
Phase 41 (14.3%)
N/A5 (71.4%)
Trials by Status
recruiting114%
terminated114%
completed571%
Recent Activity
1 active trials
Showing 5 of 7
completednot_applicable
A Silver Lining in the VAD Sky
NCT05163392
recruitingnot_applicable
Field Shield Wound Dressing Study
NCT07337616
completedphase_1
Silverlon to Reduce Radiation Dermatitis
NCT04238728
completednot_applicable
Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant
NCT02781779
terminatedphase_4
Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section
NCT01528696
Clinical Trials (7)
Showing 7 of 7 trials
NCT05163392Not Applicable
A Silver Lining in the VAD Sky
NCT07337616Not Applicable
Field Shield Wound Dressing Study
NCT04238728Phase 1
Silverlon to Reduce Radiation Dermatitis
NCT02781779Not Applicable
Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant
NCT01528696Phase 4
Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section
NCT01143883Not Applicable
Study Looking at the Effect of Silverlon on Post Operative Wound Infections
NCT00137215Not Applicable
Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7